Janux Therapeutics Inc (JANX)
47.39
+0.29
(+0.62%)
USD |
NASDAQ |
Apr 26, 16:00
47.25
-0.14
(-0.30%)
After-Hours: 20:00
Janux Therapeutics 1 Year Total Returns (Daily): 224.4% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | 224.4% |
April 25, 2024 | 218.2% |
April 24, 2024 | 220.5% |
April 23, 2024 | 223.0% |
April 22, 2024 | 217.2% |
April 19, 2024 | 205.8% |
April 18, 2024 | 218.0% |
April 17, 2024 | 222.1% |
April 16, 2024 | 245.3% |
April 15, 2024 | 254.2% |
April 12, 2024 | 274.5% |
April 11, 2024 | 259.5% |
April 10, 2024 | 230.3% |
April 09, 2024 | 198.3% |
April 08, 2024 | 187.9% |
April 05, 2024 | 187.9% |
April 04, 2024 | 203.6% |
April 03, 2024 | 194.0% |
April 02, 2024 | 196.4% |
April 01, 2024 | 211.5% |
March 28, 2024 | 234.7% |
March 27, 2024 | 227.5% |
March 26, 2024 | 237.7% |
March 25, 2024 | 235.0% |
March 22, 2024 | 248.6% |
Date | Value |
---|---|
March 21, 2024 | 245.6% |
March 20, 2024 | 234.4% |
March 19, 2024 | 223.8% |
March 18, 2024 | 225.3% |
March 15, 2024 | 193.3% |
March 14, 2024 | 163.0% |
March 13, 2024 | 190.1% |
March 12, 2024 | 175.6% |
March 11, 2024 | 183.7% |
March 08, 2024 | 152.3% |
March 07, 2024 | 150.4% |
March 06, 2024 | 166.6% |
March 05, 2024 | 164.6% |
March 04, 2024 | 160.8% |
March 01, 2024 | 187.3% |
February 29, 2024 | 190.9% |
February 28, 2024 | 180.2% |
February 27, 2024 | 198.6% |
February 26, 2024 | -1.50% |
February 23, 2024 | -8.83% |
February 22, 2024 | -14.51% |
February 21, 2024 | -24.05% |
February 20, 2024 | -43.60% |
February 16, 2024 | -42.46% |
February 15, 2024 | -44.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.27%
Minimum
Aug 31 2022
274.5%
Maximum
Apr 12 2024
-1.42%
Average
-22.75%
Median
Mar 16 2023
1 Year Total Returns (Daily) Benchmarks
Viking Therapeutics Inc | 280.1% |
Equillium Inc | 187.4% |
Minerva Neurosciences Inc | -6.29% |
Arvinas Inc | 19.31% |
Calidi Biotherapeutics Inc | -98.44% |